Not sure if this was previously shared. Bianca Ogden (highly rated biopharma fund mgr) manages the Global health sciences fund at Plantinum Asset Management. Per below June quarterly report her fund invested in the recent CR and have seen their holding double so they have trimmed their position in Clarity on the back of Cu67 8GBq single dose efficacy (?). On the other hand though were early investors in Telix since the IPO. they considered the global radiopharma peers pipeline into consideration (Clarity?) and thought the Telix valuation was stretched and they completely exited their position! Says something?
https://www.platinum.com.au/media/Platinum/Reports/pihfqtr_0624.pdf
- Forums
- ASX - By Stock
- CU6
- Research/Valuation
Research/Valuation, page-550
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
|
|||||
Last
$7.50 |
Change
-0.020(0.27%) |
Mkt cap ! $2.368B |
Open | High | Low | Value | Volume |
$7.54 | $7.64 | $7.32 | $7.764M | 1.033M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2966 | $7.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.50 | 5218 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2966 | 7.450 |
1 | 5312 | 7.440 |
1 | 134 | 7.430 |
1 | 5312 | 7.420 |
1 | 2892 | 7.410 |
Price($) | Vol. | No. |
---|---|---|
7.500 | 5218 | 1 |
7.530 | 16607 | 1 |
7.560 | 5312 | 1 |
7.580 | 5312 | 1 |
7.600 | 6312 | 3 |
Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |